ImmuPharma plc (LON:IMM – Get Free Report)’s share price rose 52.4% during trading on Monday . The company traded as high as GBX 7.14 ($0.09) and last traded at GBX 6 ($0.07). Approximately 42,676,352 shares traded hands during trading, an increase of 104% from the average daily volume of 20,960,682 shares. The stock had previously closed at GBX 3.94 ($0.05).
ImmuPharma Stock Down 13.6 %
The stock has a market cap of £21.24 million, a PE ratio of -510.00 and a beta of 1.53. The stock has a 50-day moving average of GBX 1.92 and a 200 day moving average of GBX 1.78.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Read More
- Five stocks we like better than ImmuPharma
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 3 Steel Stocks Soaring After Tariff Announcements
- Dividend Payout Ratio Calculator
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- How Investors Can Find the Best Cheap Dividend Stocks
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
